pharmaceutical-investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical-investing Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
pharmaceutical-investing Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003
pharmaceutical-investing EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
pharmaceutical-investing Pernix Therapeutics Announces Return to Market of Zohydro ER with BeadTek 20 mg
pharmaceutical-investing Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution
